📰 Materiel Development Activity News
Materiel Development Activity News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Materiel Development Activity. Real-time updates on events, politics, business and more.
April 3, 2024
60 Degrees Pharma (Nasdaq: SXTP) will sponsor a study using tafenoquine, an FDA-approved malaria drug, to treat canine babesiosis, a tick-borne disease....
February 8, 2024
To lead U.S. commercial relaunch of ARAKODA® for malaria preventionWill support Company plan to expand clinical research strategy in tick-borne diseases beyond acute babesiosis WASHINGTON,...
December 15, 2021
/PRNewswire/ -- Preliminary results of a phase II study of ARAKODA® (tafenoquine) for treatment of mild-moderate COVID-19 disease demonstrate a numerical...